Skip to search formSkip to main contentSkip to account menu

MDL 100907

Known as: MDL-100,907, MDL-100907, MDL 100,907 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

volinanserin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin
SummaryThe apparent antipsychotic action of the selective 5-HT2a receptor antagonist M100907 in MK-801-treated NMRI mice was… 
Review
2004
Review
2004
Tyr Polymorphism in the Human 5-HT 2 A Receptor Destabilizes the Signaling Conformation
Naturally occurring variation within the human 5-HT2A receptor results in an amino acid substitution in the carboxyl terminus of… 
2002
2002
Stimulus generalization by fenfluramine in a quipazine–ketanserin drug discrimination is not dependent on indirect serotonin release
Highly Cited
2001
Highly Cited
2001
m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT2C receptors but not 5-HT2A or 5-HT2B receptors
The ability of m-CPP [1-(m-chlorophenyl)piperazine] to produce hypolocomotion is well documented. This effect has been postulated… 
Review
2001
Review
2001
Could the 5-HT1B receptor inverse agonism affect learning consolidation?
1998
1998
Investigation of the CNS penetration of a potent 5-HT2a receptor antagonist (MDL 100,907) and an active metabolite (MDL 105,725) using in vivo microdialysis sampling in the rat.
1997
1997
Atypical antipsychotics block the excitatory effects of serotonin in septohippocampal neurons in the rat
1997
1997
Mixed D2/5-HT2 Antagonism Differentially Affects Apomorphine- and Amphetamine-Induced Stereotyped Behavior
1997
1997
Comparison of Neurotensin Responses to MDL 100,907, a Selective 5HT2A Antagonist, with Clozapine and Haloperidol
1996
1996
5-HT2A receptor antagonists inhibit potassium-stimulated gamma-aminobutyric acid release in rat frontal cortex.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)